Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The closing price of Viking Therapeutics Inc (NASDAQ: VKTX) was $37.21 for the day, down -0.85% from the previous closing price of $37.53. In other words, the price has decreased by -$0.85 from its previous closing price. On the day, 2.02 million shares were traded. VKTX stock price reached its highest trading level at $38.11 during the session, while it also had its lowest trading level at $36.68.
Ratios:
Our analysis of VKTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 28.34 and its Current Ratio is at 28.34. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Canaccord Genuity on October 29, 2025, initiated with a Buy rating and assigned the stock a target price of $106. On April 29, 2025, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $104. On April 08, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $30.Goldman initiated its Neutral rating on April 08, 2025, with a $30 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 28 ’25 when Mancini Marianna sold 6,185 shares for $35.00 per share. The transaction valued at 216,492 led to the insider holds 382,467 shares of the business.
Rowland Charles A Jr sold 60,000 shares of VKTX for $2,134,278 on Oct 27 ’25. The Director now owns 30,000 shares after completing the transaction at $35.57 per share. On Oct 28 ’25, another insider, Lian Brian, who serves as the President & CEO of the company, sold 38,989 shares for $35.01 each. As a result, the insider received 1,364,923 and left with 2,419,109 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VKTX now has a Market Capitalization of 4206082304 and an Enterprise Value of 3492267264.
Stock Price History:
The Beta on a monthly basis for VKTX is 0.69, which has changed by -0.20880288 over the last 52 weeks, in comparison to a change of 0.14045572 over the same period for the S&P500. Over the past 52 weeks, VKTX has reached a high of $49.67, while it has fallen to a 52-week low of $18.92. The 50-Day Moving Average of the stock is 4.84%, while the 200-Day Moving Average is calculated to be 24.21%.
Shares Statistics:
VKTX traded an average of 4.44M shares per day over the past three months and 2711200 shares per day over the past ten days. A total of 112.45M shares are outstanding, with a floating share count of 109.84M. Insiders hold about 2.83% of the company’s shares, while institutions hold 65.15% stake in the company. Shares short for VKTX as of 1764288000 were 22990072 with a Short Ratio of 5.18, compared to 1761868800 on 24173606. Therefore, it implies a Short% of Shares Outstanding of 22990072 and a Short% of Float of 24.379998.
Earnings Estimates
The company has 14.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.94, with high estimates of -$0.76 and low estimates of -$1.19.
Analysts are recommending an EPS of between -$2.07 and -$2.87 for the fiscal current year, implying an average EPS of -$2.61. EPS for the following year is -$3.72, with 13.0 analysts recommending between -$3.13 and -$4.94.
